Get the Stockscreener App
2.64
2.22%
-0.06
After Hours:
2.64
Kiora Pharmaceuticals Inc stock is traded at $2.64, with a volume of 23,686.
It is down -2.22% in the last 24 hours and up +5.60% over the past month.
Kiora Pharmaceuticals Inc is a clinical-stage biotechnology company developing and commercializing products for the treatment of orphan retinal diseases. As part of its development, KIO-301 is being studied for the treatment of retinitis pigmentosa, choroideremia, and Stargardt disease. It is a molecular photoswitch that has the potential to restore vision in patients with inherited and/or age-related retinal degeneration. KIO-104 is being developed for the treatment of posterior non-infectious uveitis. It is a next-generation, non-steroidal, immuno-modulatory, and small-molecule inhibitor of dihydroorotate dehydrogenase.
See More
Previous Close:
$2.70
Open:
$2.682738
24h Volume:
23,686
Relative Volume:
0.37
Market Cap:
$9.06M
Revenue:
-
Net Income/Loss:
$2.81M
P/E Ratio:
-0.184
EPS:
-14.3497
Net Cash Flow:
$7.14M
1W Performance:
-1.49%
1M Performance:
+5.60%
6M Performance:
-19.02%
1Y Performance:
-27.07%
1-Day Range:
$2.60
$2.7399
1-Week Range:
$2.60
$2.80
52-Week Range:
$2.25
$4.18
Kiora Pharmaceuticals Inc Stock (KPRX) Company Profile
Name
Kiora Pharmaceuticals Inc
Sector
Industry
Phone
858-224-9600
Address
169 SAXONY RD., ENCINITAS
Compare KPRX with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
KPRX
Kiora Pharmaceuticals Inc
|
2.64 | 9.30M | 0 | 2.81M | 7.14M | -14.35 |
|
VRTX
Vertex Pharmaceuticals Inc
|
394.53 | 99.62B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
465.89 | 61.52B | 2.46B | -319.09M | -52.09M | -2.47 |
|
REGN
Regeneron Pharmaceuticals Inc
|
560.00 | 58.91B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ARGX
Argen X Se Adr
|
756.38 | 46.69B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
324.34 | 34.54B | 3.81B | -644.79M | -669.77M | -6.24 |
Kiora Pharmaceuticals Inc Stock (KPRX) Latest News
Should you wait for a breakout in Kiora Pharmaceuticals Inc.Market Risk Analysis & Scalable Portfolio Growth Methods - Newser
Using RSI to spot recovery in Kiora Pharmaceuticals Inc.2025 Historical Comparison & Real-Time Stock Entry Alerts - Newser
Order flow analysis tools used on Kiora Pharmaceuticals Inc.July 2025 Highlights & Free Low Drawdown Momentum Trade Ideas - Newser
Technical signs of recovery in Kiora Pharmaceuticals Inc.Quarterly Trade Summary & Weekly Chart Analysis and Trade Guides - Newser
Volatility clustering patterns for Kiora Pharmaceuticals Inc.Earnings Overview Report & Precise Trade Entry Recommendations - Newser
Can Kiora Pharmaceuticals Inc. recover in the next quarterJuly 2025 Trends & Stepwise Trade Signal Implementation - Newser
How to recover losses in Kiora Pharmaceuticals Inc. stockLong Setup & Fast Exit/Entry Strategy Plans - Newser
Kiora Pharmaceuticals Inc. stock outlook for YEARWeekly Loss Report & Verified Stock Trade Ideas - Newser
Using data models to predict Kiora Pharmaceuticals Inc. stock movementWeekly Trade Analysis & Capital Efficiency Focused Ideas - Newser
Using data tools to time your Kiora Pharmaceuticals Inc. exitQuarterly Growth Report & Consistent Profit Trading Strategies - Newser
analyzing drawdowns of kiora pharmaceuticals inc. with statistical toolsWeekly Stock Report & Step-by-Step Swing Trade Plans - Newser
Will Kiora Pharmaceuticals Inc. stock go up soonJuly 2025 Sector Moves & Free Safe Capital Growth Stock Tips - Newser
How to integrate Kiora Pharmaceuticals Inc. into portfolio analysis toolsMarket Activity Recap & Community Verified Watchlist Alerts - Newser
Is Kiora Pharmaceuticals Inc. trending in predictive chart models2025 Retail Activity & Fast Gain Swing Trade Alerts - Newser
Combining machine learning predictions for Kiora Pharmaceuticals Inc.July 2025 Reactions & Consistent Income Trade Recommendations - Newser
Is now a turning point for Kiora Pharmaceuticals Inc.Insider Selling & AI Forecasted Stock Moves - Newser
Developing predictive dashboards with Kiora Pharmaceuticals Inc. dataPortfolio Update Report & AI Enhanced Execution Alerts - Newser
Kiora Pharmaceuticals Inc. stock prediction for this weekJuly 2025 WrapUp & Accurate Trade Setup Notifications - Newser
Technical analysis overview for Kiora Pharmaceuticals Inc. stock2025 AllTime Highs & Low Drawdown Investment Strategies - Newser
How to use a screener to detect Kiora Pharmaceuticals Inc. breakoutsNew Guidance & Free Real-Time Volume Trigger Notifications - Newser
Relative strength of Kiora Pharmaceuticals Inc. in sector analysisInflation Watch & Risk Controlled Stock Pick Alerts - Newser
Detecting support and resistance levels for Kiora Pharmaceuticals Inc.July 2025 Trade Ideas & Daily Stock Momentum Reports - Newser
Combining price and volume data for Kiora Pharmaceuticals Inc.2025 Market Overview & Consistent Income Trade Ideas - Newser
Will Kiora Pharmaceuticals Inc. see short term momentum2025 Performance Recap & AI Powered Buy/Sell Recommendations - Newser
Can Kiora Pharmaceuticals Inc. generate free cash flow2025 Market Sentiment & Risk Managed Investment Strategies - 뉴스영
Multi factor analysis applied to Kiora Pharmaceuticals Inc.Rate Hike & High Return Stock Watch Alerts - Newser
Can Kiora Pharmaceuticals Inc. benefit from deglobalization2025 Investor Takeaways & Pattern Based Trade Signal System - beatles.ru
Quantitative breakdown of Kiora Pharmaceuticals Inc. recent moveMarket Growth Report & Technical Entry and Exit Alerts - Newser
Fibonacci Retracement Aligns with Support in Kiora Pharmaceuticals Inc.Earnings Risk Report & Short-Term Swing Trade Alerts - beatles.ru
Kiora Pharmaceuticals Inc Stock (KPRX) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.93%
0.10%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):